Vitamin D: Covid-19

Opened the debate

Today, the nation faces a severe health crisis with rising death rates. David Davis highlighted that other regions like Andalusia have seen significant success in reducing death rates through vitamin D supplementation. He called for an examination of this policy experiment by the UK government and emphasised the importance of addressing vitamin D deficiency as it is linked to worse outcomes for those affected by respiratory diseases, including COVID-19. Davis pointed out that research has shown a strong correlation between vitamin D deficiency and severe symptoms of respiratory disorders such as flu, colds, pneumonia, and COVID-19. He urged the government to review the evidence urgently and implement supplementation programmes, particularly for at-risk groups like the elderly, ethnic minorities, and those with chronic conditions. Davis argued that providing supplements could save lives and reduce medical and economic costs.

Government Response

Minister Jo Churchill acknowledged the debate and emphasised the importance of reviewing new scientific evidence. She stated that while several nutrients support immune function, there is insufficient evidence linking vitamin D supplementation with reduced COVID-19 effects. The National Institute for Health and Care Excellence (NICE) published a guideline recommending everyone to take 10 micrograms of vitamin D throughout autumn and winter but concluded no sufficient proof exists to treat or mitigate the virus with vitamin D. Despite this, current government advice is to provide free four-month supplies of 10 microgram vitamin D supplements to all adults deemed clinically extremely vulnerable, not just care home residents. The minister highlighted efforts to extend supplementation access to high-risk groups and stressed ongoing research into vitamin D's impact on COVID-19.